(Q43614017)

25 November 2017

title

Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

25 November 2017

0 references

1 reference

1 reference

Constance E Ruhl

1

1 reference

25 November 2017

James E Everhart

series ordinal

2

1 reference

25 November 2017

language of work or name

English

0 references

publication date

2 April 2013

1 reference

The American Journal of Gastroenterology

25 November 2017

published in

1 reference

25 November 2017

volume

108

1 reference

25 November 2017

issue

6

1 reference

25 November 2017

page(s)

952-958

1 reference

Long-term follow-up after open cholecystectomy

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Long-term results after laparoscopic cholecystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease: is it justified?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Fatty liver, carotid disease and gallstones: a study of age-related associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Gallbladder disease is associated with insulin resistance in a high risk Hispanic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Cholelithiasis, cholecystectomy, and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Cholecystectomy increases hepatic triglyceride content and very-low-density lipoproteins production in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Prevalence and ethnic differences in gallbladder disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Executive summary: Standards of medical care in diabetes--2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Association of diabetes, serum insulin, and C-peptide with gallbladder disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Association of coffee consumption with gallbladder disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Bile Acid Pools, Kinetics and Biliary Lipid Composition before and after Cholecystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Enterohepatic circulation of bile acids after cholecystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Bile acids as regulatory molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Bile acids as regulators of hepatic lipid and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Nuclear receptors in liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.70

21 January 2018

Identifiers

DOI

10.1038/AJG.2013.70

1 reference

25 November 2017

1 reference